Capricor Therapeutics, Inc. (CAPR) vs Rezolute, Inc. (RZLT)
A side-by-side comparison of Capricor Therapeutics, Inc. and Rezolute, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAPR
Capricor Therapeutics, Inc.
$7.66HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
RZLT
Rezolute, Inc.
$4.34HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — CAPR vs RZLT
growth of $100 · dividends reinvested · last 10yCAPR -76.9% (-13.6%/yr)RZLT -94.6% (-25.3%/yr)CAPR compounded faster over this window
CAPR RZLT
CAPR vs RZLT: by the numbers
- •CAPR is the larger company ($441M vs $418M market cap).
Metrics side by side
Valuation
| Metric | CAPR | RZLT |
|---|---|---|
| P/B ratio | 1.79 | 4.15 |
| EV / EBITDA | 0.44 | N/A |
Profitability
| Metric | CAPR | RZLT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -52.56% | -77.06% |
| ROIC | -40.25% | -81.80% |
Growth (annualized)
| Metric | CAPR | RZLT |
|---|---|---|
| Total return CAGR (5Y) | 15.17% | -9.57% |
Frequently asked
- How have CAPR and RZLT total returns compared?
- Over the past 10 years, CAPR delivered -13.84% and RZLT delivered -25.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.